Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Times Interest Earned (2020 - 2025)

Xeris Biopharma Holdings' Times Interest Earned history spans 6 years, with the latest figure at $2.34 for Q4 2025.

  • For the quarter ending Q4 2025, Times Interest Earned rose 975.49% year-over-year to $2.34, compared with a TTM value of $0.85 through Dec 2025, up 177.57%, and an annual FY2025 reading of $0.86, up 177.55% over the prior year.
  • Times Interest Earned for Q4 2025 was $2.34 at Xeris Biopharma Holdings, up from $0.92 in the prior quarter.
  • The five-year high for Times Interest Earned was $2.34 in Q4 2025, with the low at -$26.88 in Q4 2021.
  • Average Times Interest Earned over 5 years is -$4.69, with a median of -$2.08 recorded in 2023.
  • Year-over-year, Times Interest Earned plummeted 543.47% in 2021 and then soared 975.49% in 2025.
  • Tracing XERS's Times Interest Earned over 5 years: stood at -$26.88 in 2021, then surged by 87.08% to -$3.47 in 2022, then skyrocketed by 59.58% to -$1.4 in 2023, then surged by 115.49% to $0.22 in 2024, then soared by 975.49% to $2.34 in 2025.
  • Per Business Quant, the three most recent readings for XERS's Times Interest Earned are $2.34 (Q4 2025), $0.92 (Q3 2025), and $0.61 (Q2 2025).